These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11453328)

  • 21. The impact of a general practice group intervention on prescribing costs and patterns.
    Walker J; Mathers N
    Br J Gen Pract; 2002 Mar; 52(476):181-6. PubMed ID: 12030659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in prescribing of antihypertensive drugs in Australia, 1977-1987.
    Hurley SF; Williams SL; McNeil JJ
    Med J Aust; 1990 Mar; 152(5):259-60, 263-6. PubMed ID: 1979421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.
    Stafford RS; Furberg CD; Finkelstein SN; Cockburn IM; Alehegn T; Ma J
    JAMA; 2004 Jan; 291(1):54-62. PubMed ID: 14709576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
    Chiang CW; Chen CY; Chiu HF; Wu HL; Yang CY
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):412-21. PubMed ID: 17252613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension.
    Klarenbach SW; McAlister FA; Johansen H; Tu K; Hazel M; Walker R; Zarnke KB; Campbell NR;
    Can J Cardiol; 2010 May; 26(5):e158-63. PubMed ID: 20485695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of guidelines for antihypertensive care in Finland.
    Booth N; Jula A; Aronen P; Kaila M; Klaukka T; Kukkonen-Harjula K; Reunanen A; Rissanen P; Sintonen H; Mäkelä M
    BMC Health Serv Res; 2007 Oct; 7():172. PubMed ID: 17958883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan.
    Liu PH; Wang JD
    BMC Health Serv Res; 2008 Jun; 8():133. PubMed ID: 18559115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug utilization among hypertensive patients in the outpatient department of medicine in a tertiary care hospital: A cross-sectional study.
    Paradkar SG; Sinha SR
    Clin Exp Hypertens; 2018; 40(2):150-154. PubMed ID: 28816547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic implications of evidence-based prescribing for hypertension: can better care cost less?
    Fischer MA; Avorn J
    JAMA; 2004 Apr; 291(15):1850-6. PubMed ID: 15100203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing family physician adherence to hypertension treatment guideline recommendations on the initiation of pharmacotherapy: questionnaire survey.
    Nelson MR; Reid CM; Krum H; McNeil JJ
    Am J Cardiovasc Drugs; 2003; 3(6):437-41. PubMed ID: 14728063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
    Prosser H; Walley T
    Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of prescribing, dispensing, and patient use pattern of antihypertensive drugs for patients attending outpatient department of Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia.
    Shukrala F; Gabriel T
    Drug Des Devel Ther; 2015; 9():519-23. PubMed ID: 25632220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fundholders' prescribing costs: the first five years.
    Harris CM; Scrivener G
    BMJ; 1996 Dec; 313(7071):1531-4. PubMed ID: 8978232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rising prescription drug costs: whose responsibility?
    Hill SR; Henry DD; Smith AJ
    Med J Aust; 1997 Jul; 167(1):6-7. PubMed ID: 9236749
    [No Abstract]   [Full Text] [Related]  

  • 35. Antihypertensive Prescribing Pattern in Older Adults: Implications of Age and the Use of Dual Single-Pill Combinations.
    Al Khaja KAJ; James H; Veeramuthu S; Tayem YI; Sridharan K; Sequeira RP
    High Blood Press Cardiovasc Prev; 2019 Dec; 26(6):535-544. PubMed ID: 31797221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rational prescribing in patients with arterial hypertension].
    Torres Pacho JA; Mora Guío FJ; Charques Velasco E; Alonso Martínez MM
    Gac Sanit; 2002; 16(2):196-7; author reply 197. PubMed ID: 11958758
    [No Abstract]   [Full Text] [Related]  

  • 37. The influence of national guidelines on antihypertensive prescribing patterns.
    Siegel D
    Curr Hypertens Rep; 2000 Jun; 2(3):247-52. PubMed ID: 10981157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing the cost of proton pump inhibitors by adopting best practice.
    Hughes JD; Tanpurekul W; Keen NC; Ee HC
    Qual Prim Care; 2009; 17(1):15-21. PubMed ID: 19281670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liothyronine (LT3) prescribing in England: Are cost constraints inhibiting guideline implementation?
    Ah H; Ld P; Pn T; Depesina D; Chaudhury N; Oe O; M S; Cm D
    Clin Endocrinol (Oxf); 2024 Jul; 101(1):62-68. PubMed ID: 38752469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.